Viability of red cells prepared with S‐303 pathogen inactivation treatment
Authors:
- 21 September 2006
- journal article
- research article
- Published by Wiley in Transfusion
- Vol. 46 (10) , 1778-1786
Abstract
BACKGROUND: A nucleic acid–targeted pathogen inactivation process with S‐303 was developed to treat red blood cells (RBCs).STUDY DESIGN AND METHODS: Three studies in healthy subjects investigated posttransfusion recovery, life span, and immunogenic potential of autologous RBCs treated with S‐303 and stored for 35 days. A two‐arm trial in 42 subjects (1A) examined recovery of 35‐day‐old S‐303 RBCs after a single transfusion. A one‐arm study (1B) measured recovery and immune response in 28 subjects after multiple transfusions of S‐303 RBCs. A randomized, crossover study (1C) in 29 subjects compared recovery and life span of 35‐day‐old S‐303 RBCs and conventional RBCs.RESULTS: In Studies 1A and 1B, mean recovery of S‐303 RBCs ranged from 78.7 to 84.4 percent. In Phase 1C, the mean 24‐hour posttransfusion recoveries of S‐303 and untreated RBCs were 81.7 ± 6.3 and 84.5 ± 6.2 percent (p = 0.05). The median life spans (t1/2) of S‐303 and control RBCs were identical (37.4 days, p = 0.98). No antibodies to S‐303 RBCs were detected.CONCLUSION: The mean 24‐hour recovery of 35‐day‐old S‐303 RBCs was less than untreated RBCs, but greater than 75 percent. RBCs treated with S‐303 and stored for 35 days exhibited median life span not different from that of conventional RBCs.Keywords
This publication has 25 references indexed in Scilit:
- Therapeutic efficacy and safety of red blood cells treated with a chemical process (S‐303) for pathogen inactivation: a Phase III clinical trial in cardiac surgery patientsTransfusion, 2005
- The validity of serologic tests for Trypanosoma cruzi and the effectiveness of transfusional screening strategies in a hyperendemic regionTransfusion, 2005
- Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT TrialBlood, 2004
- Photochemical pathogen reduction: improved safety for the blood supply?Blood, 2003
- Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2000
- Transfusion‐associated transmissionof babesiosis in New York StateTransfusion, 2000
- Correlation between in vivo hemolysis and the amount of red cell‐bound IgG measured by flow cytometryTransfusion, 1990
- Methods of determining the posttransfusion survival of stored red cellsTransfusion, 1984
- Proposed standardization of methods for determining the 24‐hour survival of stored red cellsTransfusion, 1984
- Evaluating the survival of stored red cellsTransfusion, 1984